Can Electronic Decision Support Tools Really Reduce Mortality from Community-acquired Pneumonia?

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2022 Mar 23

PMID 35320063

Authors

Grant Waterer

Gavin Donaldson

Affiliations

Soon will be listed here.

References

Jones B, Ying J, Stevens V, Haroldsen C, He T, Nevers M . Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia. JAMA Intern Med. 2020; 180(4):552-560. PMC: 7042818. DOI: 10.1001/jamainternmed.2019.7495. View

Waterer G, Self W, Courtney D, Grijalva C, Balk R, Girard T . In-Hospital Deaths Among Adults With Community-Acquired Pneumonia. Chest. 2018; 154(3):628-635. PMC: 6859251. DOI: 10.1016/j.chest.2018.05.021. View

Webb B, Sorensen J, Jephson A, Mecham I, Dean N . Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study. Eur Respir J. 2019; 54(1). DOI: 10.1183/13993003.00057-2019. View

Attridge R, Frei C, Pugh M, Lawson K, Ryan L, Anzueto A . Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes. J Crit Care. 2016; 36:265-271. PMC: 5096991. DOI: 10.1016/j.jcrc.2016.08.004. View

Metlay J, Waterer G, Long A, Anzueto A, Brozek J, Crothers K . Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019; 200(7):e45-e67. PMC: 6812437. DOI: 10.1164/rccm.201908-1581ST. View

Marrie T, Lau C, Wheeler S, Wong C, Vandervoort M, Feagan B . A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000; 283(6):749-55. DOI: 10.1001/jama.283.6.749. View

Dean N, Vines C, Carr J, Rubin J, Webb B, Jacobs J . A Pragmatic, Stepped-Wedge, Cluster-controlled Clinical Trial of Real-Time Pneumonia Clinical Decision Support. Am J Respir Crit Care Med. 2022; 205(11):1330-1336. PMC: 9873107. DOI: 10.1164/rccm.202109-2092OC. View

Yealy D, Auble T, Stone R, Lave J, Meehan T, Graff L . Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med. 2005; 143(12):881-94. DOI: 10.7326/0003-4819-143-12-200512200-00006. View

Ruhnke G, Coca-Perraillon M, Kitch B, Cutler D . Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia. Am J Med. 2011; 124(2):171-178.e1. PMC: 3064506. DOI: 10.1016/j.amjmed.2010.08.019. View

10.

Restrepo M, Mortensen E, Rello J, Brody J, Anzueto A . Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest. 2009; 137(3):552-7. PMC: 3021366. DOI: 10.1378/chest.09-1547. View

11.

Simpson J, Macfarlane J, Watson J, Woodhead M . A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. British Thoracic Society Research Committee and Public Health Laboratory Service. Thorax. 2000; 55(12):1040-5. PMC: 1745667. DOI: 10.1136/thorax.55.12.1040. View

12.

Dean N, Jones B, Jones J, Ferraro J, Post H, Aronsky D . Impact of an Electronic Clinical Decision Support Tool for Emergency Department Patients With Pneumonia. Ann Emerg Med. 2015; 66(5):511-20. DOI: 10.1016/j.annemergmed.2015.02.003. View

13.

Gattarello S, Borgatta B, Sole-Violan J, Valles J, Vidaur L, Zaragoza R . Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000-2013). Chest. 2013; 146(1):22-31. DOI: 10.1378/chest.13-1531. View